“心血管XXX主任”、“成都XXX”、“麻辣XXX”等账号，被处置

Core Viewpoint - The article discusses the recent actions taken by the Central Cyberspace Administration and the National Medical Insurance Administration to address false information related to centralized procurement of pharmaceuticals and medical supplies, emphasizing the importance of accurate information in this sector [1][2]. Group 1: Actions Against Misinformation - Several social media accounts have been identified for spreading false information that stigmatizes centralized procurement policies to gain traffic, including accounts on platforms like Xiaohongshu and Douyin [1]. - Accounts have been found to incite public anxiety by distorting national policies and spreading false claims, such as the alleged collective withdrawal of imported drugs from China, which aims to create a sense of urgency among the public [2]. - Certain accounts have been misleadingly associating non-procurement products with procurement policies, thereby damaging the credibility of the procurement system [2]. Group 2: Public Awareness and Responsibility - The article highlights the significance of the centralized procurement policy for the public's interests and warns that the fabrication and dissemination of false information regarding this policy will face strict penalties [2]. - The authorities urge the public to adopt a rational, objective, and scientific perspective on pharmaceutical procurement, encouraging them not to spread rumors or believe in misinformation [2].